Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3

Endocrine-Related Cancer

Volumn 17, Issue 1, 2010, Pages 51-60

  Fowke, Jay H ^a   Matthews, Charles E ^a   Yu, Herbert ^b   Cai, Qiuyin ^a   Cohen, Sarah ^c   Buchowski, Maciej S ^a   Zheng, Wei ^a   Blot, William J ^a,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b YALE UNIVERSITY   (United States)

^c INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PREMENOPAUSE; RACE DIFFERENCE;

ADULT; AFRICAN AMERICANS; AGE OF ONSET; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDIES; SOUTHEASTERN UNITED STATES; YOUNG ADULT;

EID: 77449140971     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0023     Document Type: Article

References (38)

1. Allen NE, Roddam AW, Allen DS, Fentiman IS, Dos Santos Silva I, Peto J, Holly JM & Key TJ 2005 A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. British Journal of Cancer 92 1283-1287.
2. Berrigan D, Potischman N, Dodd KW, Nicar M, McQuillan G, Lavigne JA, Barrett JC & Ballard-Barbash R 2007 Serum levels of insulin-like growth factor-I and insulinlike growth factor-I binding protein-3: quality control for studies of stored serum. Cancer Epidemiology, Biomarkers & Prevention 16 1017-1022.
3. Berrigan D, Potischman N, DoddKW, Hursting SD, Lavigne J, Barrett JC&Ballard-Barbash R 2008 Race/ethnic variation in serumlevels of IGF-I and IGFBP-3 in US adults. Growth Hormone & IGF Research 19 146-155.
4. Brinton LA, Sherman ME, Carreon JD & Anderson WF 2008 Recent trends in breast cancer among younger women in the United States. Journal of the National Cancer Institute 100 1643-1648.
5. Clemmons DR & Underwood LE 1991 Nutritional regulation of IGF-I and IGF binding proteins. Annual Review of Nutrition 11 393-412.
6. DeLellis K, Rinaldi S, Kaaks RJ, Kolonel LN, Henderson B & Le Marchand L 2004 Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the Multiethnic Cohort. Cancer Epidemiology, Biomarkers & Prevention 13 1444-1451.
7. Egan KM, Signorello LB, Munro HM, Hargreaves MK, Hollis BW & Blot WJ 2008 Vitamin D insufficiency among African-Americans in the Southeastern United States: implications for cancer disparities (United States). Cancer Causes & Control 19 527-535.
8. Figueroa JA, Jackson JG, McGuire WL, Krywicki RF & Yee D 1993 Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. Journal of Cellular Biochemistry 52 196-205.
9. Flegal KM, Carroll MD, Ogden CL & Johnson CL 2002 Prevalence and trends in obesity among US adults, 1999-2000. Journal of the American Medical Association 288 1723-1727.
10. Fowke JH, Matthews CM, Buchowski MS, Signorello LB, Chang SS, Cookson MS & Blot WJ 2008 Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men. Prostate Cancer and Prostatic Diseases 11 264-269.
11. Gapstur SM, Kopp P, Chiu BCH, Gann PH, Colangelo LA & Liu K 2004 Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in black and white men: the CARDIA Male Hormone Study. Cancer Epidemiology, Biomarkers & Prevention 13 2208-2216.
12. Gennigens C, Menetrier-Caux C & Droz JP 2006 Insulin-like growth factor (IGF) family and prostate cancer. Critical Reviews in Oncology/Hematology 58 124-145.
13. Gram IT, Norat T, Rinaldi S, Dossus L, Lukanova A, Tehard B, Clavel-Chapelon F, van Gils CH, van Noord PA, Peeters PH et al. 2006 Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. International Journal of Obesity 30 1623-1631.
14. Gronbaek H, Flyvbjerg A, Mellemkjaer L, Tjonneland A, Christensen J, Sorensen HT & Overvad K 2004 Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention 13 1759-1764.
15. Hall IJ, Newman B, Millikan RC & Moorman PG 2000 Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study. American Journal of Epidemiology 151 754-764.
16. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R et al. 1996 Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. Journal of Clinical Investigation 98 2612-2615.
17. Hausauer AK, Keegan TH, Chang ET & Clarke CA 2007 Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype. Breast Cancer Research 9 R90.
18. Henderson KD, Goran MI, Kolonel LN, Henderson BE & Le ML 2006 Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the Multiethnic Cohort. Cancer Epidemiology, Biomarkers & Prevention 15 2298-2302.
19. Holmes MD, Pollak MN, Willett WC & Hankinson SE 2002 Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiology, Biomarkers & Prevention 11 852-861.
20. Janssen JA, Stolk RP, Pols HA, Grobbee DE, de Jong FH & Lamberts SW 1998 Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clinical Endocrinology 48 471-478.
21. Jernström H, Chu W, Vesprini D, Tao Y, Majeed N, Deal C, Pollak M & Narod SA 2001a Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Molecular Genetics and Metabolism 72 144-154.
22. Jernstrom H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA & Pollak M 2001b Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiology, Biomarkers & Prevention 10 377-384.
23. Jorgensen JO, Christensen JJ, Krag M, Fisker S, Ovesen P & Christiansen JS 2004 Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids. Hormone Research 62 73-76.
24. Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P et al. 2004 Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. European Journal of Endocrinology 150 161-171.
25. Mayberry RM 1994 Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54. Annals of Epidemiology 4 205-213.
26. McGreevy K, Hoel B, Lipsitz S & Hoel D 2007 Impact of nutreints on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and their ratio in African American and white males. Public Health Nutrition 10 97-105.
27. Michels KB, Terry KL & Willett WC2006 2006 Longitudinal study on the role of body size in premenopausal breast cancer. Archives of Internal Medicine 166 2395-2402.
28. Palmer JR, dams-Campbell LL, Boggs DA, Wise LA & Rosenberg L 2007 A prospective study of body size and breast cancer in black women. Cancer Epidemiology, Biomarkers & Prevention 16 1795-1802.
29. Pfeiffer RM, Mitani A, Matsuno RK & Anderson WF 2008 Racial differences in breast cancer trends in the United States (2000-2004). Journal of the National Cancer Institute 100 751-752.
30. Pinheiro SP, Holmes MD, Pollak MN, Barbieri RL & Hankinson SE 2005 Racial differences in premenopausal endogenous hormones. Cancer Epidemiology, Biomarkers & Prevention 14 2147-2153.
31. Probst-Hensch NM, Wang H, Goh VHH, Seow A, Lee HP & Yu MC 2003 Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiology, Biomarkers & Prevention 12 739-746.
32. Renehan AG, Harvie M & Howell A 2006 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on. Endocrine-Related Cancer 13 273-278.
33. Rozen F, Yang XF, Huynh H & Pollak M 1997 Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation. Journal of the National Cancer Institute 89 652-656.
34. Schernhammer ES, Tworoger SS, Eliassen AH, Missmer SA, Holly JM, Pollak MN & Hankinson SE 2007 Body shape throughout life and correlations with IGFs and GH. Endocrine-Related Cancer 14 721-732.
35. Setiawan VW, Haiman CA, Stanczyk FZ, Le Marchand L & Henderson BE 2006 Racial/ethnic differences in post-menopausal endogenous hormones: the Multiethnic Cohort Study. Cancer Epidemiology, Biomarkers & Prevention 15 1849-1855.
36. Signorello LB, Hargreaves MK, Steinwandel MD, Zheng W, Cai Q, Schlundt DG, Buchowski MS, Arnold CW, McLaughlin JK & Blot WJ 2005 Southern community cohort study: establishing a cohort to investigate health disparities. Journal of the National Medical Association 97 972-979.
37. Suga K, Imai K, Eguchi H, Hayashi S, Higashi Y & Nakachi K 2001 Molecular significance of excess body weight in postmenopausal breast cancer patients, in relation to expression of insulin-like growth factor I receptor and insulin-like growth factor II genes. Japanese Journal of Cancer Research 92 127-134.
38. Zhu K, Caulfield J, Hunter S, Roland CL, Payne-Wilks K & Texter L 2005 Body mass index and breast cancer risk in African American women. Annals of Epidemiology 15 123-128.